ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,816 companies indexed · Last updated: today
DirectoryAssociations & Interest GroupsNGOs & NPOsGenevaDrugs for Neglected Diseases initiative (DNDi)
Drugs for Neglected Diseases initiative (DNDi) Logo
Verified· 2 sources

Drugs for Neglected Diseases initiative (DNDi)

Summary

About the company

The company's core activity is the development and provision of medical treatments, particularly for neglected tropical diseases (NTDs) and viral diseases, including pandemic and climate-related diseases. The company focuses on developing new treatments to improve accessibility and affordability for patients in low- and middle-income countries.

AI-generated
Offering

Products & services

Industry:NGOs & NPOsResearch & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered8
Drug development for neglected diseases
Development of life-saving therapies for neglected patients, from active ingredient research through translational research and clinical trials to registration and access.
Research and treatment access projects
A portfolio of more than 40 research and access projects, including initiatives to identify new chemical entities and to improve access to treatments.
Policy advocacy for open and collaborative R&D
Advocacy for public accountability, open and collaborative research, better priority-setting, coordination and sustainable funding in the biomedical R&D system.
Policy advocacy for cost transparency in R&D
Advocacy for transparency of R&D costs, accountability and fair medicine prices, so that innovations remain accessible and affordable.
Policy advocacy for access-friendly patent and licensing policy
Advocacy to ensure that intellectual property rights do not hinder access and the introduction of new treatments.

Knowledge

No knowledge articles yet

Once Drugs for Neglected Diseases initiative (DNDi) has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Drugs for Neglected Diseases initiative (DNDi) in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Drugs for Neglected Diseases initiative (DNDi) by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Drugs for Neglected Diseases initiative (DNDi) to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Chemin Camille-VIDART 15
1202 Geneva

At a glance

Legal form
Foundation
UID
CHE-110.141.200
Founded
2003 · 23 years
Last commercial register change
June 5, 2026
Employees
101 to 500

Similar companies

GF
GARDP Foundation
Geneva
FE
Fondation EspeRare
Geneva
NP
Nonviolent Peaceforce International
Geneva
AW
Association World Vision International
Geneva
QF
Quantum FutureX
Geneva
SI
Simon Institute for Longterm Governance
Geneva
C
Caritas-Genève
Geneva
GA
GAVI Alliance
Le Grand-Saconnex